Skip to content

Viant Technology Inc. DSP Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

The Trade Desk logo
The Trade DeskTTD
FuboTV
 logo
FuboTV FUBO

Other financials

Income statement

See full
Revenue$88.5M+25.3%
Gross profit$36.4M+19.0%
Operating income-$4.0M+18.5%
Net income-$455.0K+61.8%
EPS (diluted)-$0.03+57.1%

Balance sheet

See full
Cash & equivalents$185.7M+6.8%
Total debt$23.4M-6.4%
Total equity$85.3M+134%
Total assets$439.0M+11.3%

Cash flow

See full
Operating cash flow$2.9M+166%
CapEx$313.0K+152%
Free cash flow$2.6M+157%

Valuation

See full
Market cap$253.47M+20.6%
Enterprise value$91.17M+47.0%
P/E27.9×-61.4×
P/S0.7×0.0×

Profitability

See full
Gross margin45.1%-0.3pp
Operating margin3.6%+2.2pp
Net margin2.5%+1.8pp
FCF margin16.3%+2.8pp

Returns & leverage

See full
Return on equity14.9%+10.8pp
Debt / equity0.3×-0.4×
Current ratio2.9×+0.2×

Where this comes from

Reported directly by Viant Technology Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Viant Technology Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viant Technology Inc.'s cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viant Technology Inc.'s cash and cash equivalents, end of period?
Viant Technology Inc. (DSP) reported cash and cash equivalents, end of period of $185.69M in Q1 2026.
How has Viant Technology Inc.'s cash and cash equivalents, end of period changed year-over-year?
Viant Technology Inc.'s cash and cash equivalents, end of period increased by 6.8% year-over-year, from $173.88M to $185.69M.
What is the long-term trend for Viant Technology Inc.'s cash and cash equivalents, end of period?
Over 4 years (2021 to 2025), Viant Technology Inc.'s cash and cash equivalents, end of period has grown at a -5.4% compound annual growth rate (CAGR), from $238.48M to $191.15M.